Explore
Trendline
Stoke Therapeutics to Present Zorevunersen at Needham Virtual Healthcare Conference
Stoke Therapeutics to Present Zorevunersen at Needham Virtual Healthcare Conference
Read More
Trendline
Stoke Therapeutics Appoints Clare Kahn, Ph.D., to Board Amid Dravet Syndrome Treatment Advancements
Stoke Therapeutics Appoints Clare Kahn, Ph.D., to Board Amid Dravet Syndrome Treatment Advancements
Read More
Trendline
Stoke Therapeutics Appoints Clare Kahn, Ph.D., to Board Amid Dravet Syndrome Treatment Advances
Stoke Therapeutics Appoints Clare Kahn, Ph.D., to Board Amid Dravet Syndrome Treatment Advances
Read More
Trendline
Gilead Sciences to Acquire Tubulis for $5 Billion, Enhancing Cancer Treatment Capabilities
Gilead Sciences to Acquire Tubulis for $5 Billion, Enhancing Cancer Treatment Capabilities
Read More
Trendline
Orano Med Appoints Frederic Desdouits as CEO to Drive Biotech Innovations
Orano Med Appoints Frederic Desdouits as CEO to Drive Biotech Innovations
Read More
Trendline
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference
Read More
Trendline
Amylyx Pharmaceuticals to Present at Virtual Healthcare Conference
Amylyx Pharmaceuticals to Present at Virtual Healthcare Conference
Read More
Trendline
Autobahn Therapeutics to Present at Needham Virtual Healthcare Conference
Autobahn Therapeutics to Present at Needham Virtual Healthcare Conference
Read More
Trendline
Evommune to Highlight MRGPRX2 Inhibition Potential in Migraine Treatment
Evommune to Highlight MRGPRX2 Inhibition Potential in Migraine Treatment
Read More
Trendline
Evommune to Explore MRGPRX2 Inhibition for Migraine Treatment
Evommune to Explore MRGPRX2 Inhibition for Migraine Treatment
Read More
Trendline
Vyome to Present Phase 2 Clinical Data on VT-1953 for MFW Treatment at AACR 2026
Vyome to Present Phase 2 Clinical Data on VT-1953 for MFW Treatment at AACR 2026
Read More
Trendline
Decoy Therapeutics to Host Virtual Investor Event on Business Outlook for 2026
Decoy Therapeutics to Host Virtual Investor Event on Business Outlook for 2026
Read More
